Swiggy has signed a $700 million funding round led by asset manager Invesco. With this, the total valuation of Swiggy has reached to $10.7 billion i.e. it is now a decacorn.
The initial construct and production process of the vaccine antigen was developed at TCH's Centre for Vaccine Development. V. G. Somani :- Drugs Controller General of India.
EXAMIANS